391
Views
6
CrossRef citations to date
0
Altmetric
Articles

The highs and lows of NPS/“Legal High” use: Qualitative views from a UK online survey

, , &
Pages 96-102 | Received 09 Jun 2016, Accepted 09 Jun 2016, Published online: 08 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David Subeliani, David Otiashvili, Lika Kutelia, Ada Beselia, Tamar Mgebrishvili, Irina Vardanashvili & Irma Kirtadze. (2020) Patterns of use of new psychoactive substances and perceived benefits and negative effects: results of online survey in Georgia (country). Journal of Substance Use 25:3, pages 324-329.
Read now
Ian P. Albery, Antony C. Moss, Nicola Davidson, S. Mba, Ursula Blaszko & Alexander P. Marchant. (2018) Selective attentional bias for novel psychoactive substance (NPS) and expectancy-related stimuli among nonproblematic NPS users and never NPS users. Journal of Substance Use 23:4, pages 422-428.
Read now

Articles from other publishers (3)

Sarah Simonis, Michaël Canfyn, Anton Van Dijck, Tina Van Havere, Eric Deconinck, Peter Blanckaert & Lies Gremeaux. (2020) Awareness of users and motivational factors for using new psychoactive substances in Belgium. Harm Reduction Journal 17:1.
Crossref
Annemieke Benschop, Róbert Urbán, Máté Kapitány-Fövény, Marie Claire Van Hout, Katarzyna Dąbrowska, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Joana Paula Silva, Łukasz Wieczorek, Bernd Werse, Michal Bujalski, Dirk Korf & Zsolt Demetrovics. (2020) Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology 34:6, pages 600-611.
Crossref
Kathryn Higgins, Nina O’Neill, Leeanne O’Hara, Julie-Ann Jordan, Mark McCann, Tara O’Neill, Mike Clarke, Tony O’Neill & Anne Campbell. (2019) Evidence for public health on novel psychoactive substance use: a mixed-methods study. Public Health Research 7:14, pages 1-150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.